Biomason
Biomason is a biotechnology company that uses microorganisms to grow biocement tiles, pavers, and precast products as a zero-Portland, lower-CO2 alternative to conventional cement, serving construction, real estate, retail, and defense customers.
- Company typePrivate
- Founded2012
- HeadquartersDurham, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biomason does
Biomason is a biotechnology company founded in 2012 by Ginger Krieg Dosier and Michael Dosier that develops biocement as a structural replacement for Portland cement. Its process uses naturally-occurring microorganisms to grow calcium carbonate crystals that bind aggregate particles at ambient temperatures, eliminating the high-heat kiln step and reducing CO2 emissions by up to 60% versus conventional cement; products contain zero Portland cement. The company's core product line includes Biolith Tiles, BioBasedTiles co-developed with StoneCycling, pavers and blocks, with large-format precast walls in development. In July 2023, the Biobeton factory in Ikast, Denmark, qualified as the world's first industrial-scale biocement facility and is operated in partnership with IBF.
The company's customer base spans real estate developers and architecture firms (FORE, AKF, Lendager), retail and consumer brands (H&M via its Circular Innovation Lab), defense and government agencies (DARPA, the Air Force Research Laboratory, and Army-SBIR), and concrete and aggregate producers (IBF, Martin Marietta). Biomason pursues a hybrid go-to-market combining direct sales of branded tiles and pavers to construction and real estate customers with technology licensing to incumbent concrete producers. Pricing is project-based and custom-quoted rather than standardized SKU distribution.
The company has raised a $65M Series C in February 2022 led by 2150, with a further raise of approximately $36.67M reported in 2025, and operates with 55+ employees. In March 2024, Camilo Restrepo joined as CEO from Argos USA, bringing 19 years of cement industry experience to lead the scale-up from pilot to industrial production.
Biomason firmographics
Firmographics- Name
- Biomason
- Legal name
- Biomason, Inc.
- Website
- https://biomason.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Biomason is a biotechnology company that uses microorganisms to grow biocement tiles, pavers, and precast products as a zero-Portland, lower-CO2 alternative to conventional cement, serving construction, real estate, retail, and defense customers.
- Ownership category
- akta.pro rank
Biomason industry classification
Industry- Product category
- Sustainable construction materials
- NAICS
- Cement Manufacturing (327310), Cement and Concrete Product Manufacturing (3273), Other Concrete Product Manufacturing (327390)
- SIC
- Cement, Hydraulic (3241), Concrete, Gypsum & Plaster Products (3270), Industrial Inorganic Chemicals (2810)
- akta.pro primary industry
- Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB)
- akta.pro secondary industry
- Bio-based Resins, Adhesives, Coatings & Sealants (EUAAAIAG)
Keywords
Where Biomason is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Biomason business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Biocement Products Sales: Direct sales of biocement-based concrete products including tiles, pavers, and precast elements to construction companies, developers, and building projects. Products contain zero Portland cement and are manufactured at the Biobeton factory in Denmark.
- Technology Licensing: Licensing biocement technology to concrete producers. The company offers an alternative production method to concrete producers who are squeezed between cement producers and customers. Using common materials reduces unit cost and increases margin for concrete producers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Enterprise sales of biocement tiles and precast products |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Biomason product offering
Product offeringCore offering
Biomason develops, manufactures, and sells biocement-based concrete products including floor tiles, pavers, blocks, and large-format precast walls. Products are made using a proprietary process in which naturally occurring microorganisms precipitate calcium carbonate crystals at ambient temperatures, binding aggregate particles into structural concrete that contains zero Portland cement and reduces CO2 emissions by up to 60% versus traditional cement. Manufacturing is conducted at the Biobeton factory in Ikast, Denmark, in partnership with IBF, with US production from the Concrete Development and Production Center in Research Triangle Park, NC.
Product overview
Biomason offers a biocement-based product portfolio centered on its proprietary calcium carbonate biocement technology that replaces Portland cement in concrete production. The core technology uses bacteria to grow calcium carbonate crystals at ambient temperatures, binding aggregate into concrete products that sequester carbon. The commercial product line includes Biolith Tiles (available since 2020), BioBasedTiles (in partnership with StoneCycling), and traditional pavers and blocks. Additional products including large format precast walls are in technology development phase. All products are manufactured at the Biobeton factory in Denmark, which uses adapted industrial equipment including mixers, presses, and curing systems.
Differentiator
Problem solved
Functional benefit
Products and services
- Biocement Proprietary cement alternative grown at ambient temperatures using naturally occurring microorganisms that precipitate calcium carbonate crystals to bind aggregate particles. Replaces Portland cement in concrete production with zero Portland cement content and up to 60% lower CO2 emissions. Sold to concrete producers, developers, and construction projects globally.
- Biolith Tile Commercial floor tile product made with Biomason's biocement, meeting compressive and flexural strength requirements comparable to traditional concrete. Available for installation in the US and Europe, sold to commercial and residential construction projects.
- BioBasedTiles Low-carbon floor tile line co-developed with StoneCycling to drive adoption of sustainable building materials throughout Europe. Marketed jointly through Biomason and StoneCycling channels.
- Biocement Pavers and Blocks Concrete paver and block products manufactured using Biomason's biocement technology, leveraging adapted industrial pressing and curing equipment. First installation at Dropbox HQ in California in 2015; now produced at scale at the Biobeton factory in Ikast, Denmark.
- Large-Format Precast Walls Large-format precast wall products including the 15-foot Revetment Wall and Carolina Barrier, developed for military, infrastructure, and coastal protection applications. Produced under DARPA, AFRL, and Army-SBIR contracts.
Quantifiable outcome
- Up to 60% reduction in CO2 emissions compared to traditional cement production
- +4 more outcomes
Companies that use Biomason
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Biomason technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Biomason partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, core, major and supporting.
- IBFflagshipPartnership with IBF, the largest producer of precast concrete in Denmark, to develop and operate the Biobeton factory in Ikast, Denmark. The 3-year partnership resulted in world's first biocement factory qualified in July 2023.
- H&M GroupcorePartnership with H&M's Circular Innovation Lab to develop large, thin tiles for sustainable retail spaces. H&M HQ tiles installed at Stockholm headquarters.
- FRONTcoreArchitecture firm that collaborates with Biomason on BioBasedTiles products and sustainable building projects including TRÆ building in Aarhus and Tower Bridge Court in London.
- AP PensioncoreInvestment partnership for sustainable building materials. Installed biocement tiles at Helix Lab research center in Kalundborg, Denmark.
- StoneCyclingcorePartnership announced June 2022 to launch BioBasedTiles product to propel adoption of low-carbon building materials throughout Europe.
- 3XN/GXNmajorArchitecture firm collaboration on BioConcrete project - growing low-carbon structures with bacteria as part of Reset Materials at Copenhagen Contemporary. Large bioconcrete structures exhibited in 2023.
- US Army Corps of EngineersmajorGovernment partnership for military applications of biocement technology.
- AFRL (Air Force Research Laboratory)majorAFRL contract to develop biocement infrastructure for runway and airfield augmentation.
- DARPAmajorMultiple DARPA contracts including: Embedded Entrepreneurship Initiative (2021), Engineered Living Marine Cement (ELMc) using self-sustaining marine microorganisms with self-healing abilities (2017), and dust control for vertical take-off and landing operations (2021).
- SBIR (Small Business Innovation Research)coreArmy-SBIR contract to further develop large format precast through biocement barriers for military applications.
- AKF GroupcoreDanish property developer that installed biocement floor tiles at Kirkebjerg Lake Park project in Brondby, Denmark.
- FORE PartnershipcoreReal estate firm active in UK and Europe that developed Tower Bridge Court project using Biomason biocement tiles for net zero carbon landmark in London.
- North Carolina Biotechnology CentersupportingInitial office location at NC Biotechnology Center in Research Triangle Park when company was founded in 2013.
Scale indicators9 records
Recent moves11 records
Expansion highlights7 records
Biomason competitors and assessment
Company assessmentDirect peers
- CarbonCure Technologies: Canadian startup that injects captured CO2 into ready-mix concrete to permanently mineralize it within the cement matrix. Most direct competitor to Biomason in commercial-scale low-carbon concrete technologies, with industry-wide adoption among concrete producers.
- Solidia Technologies: Developer of a CO2-cured concrete process that reduces cement content and sequesters carbon during curing. Comparable to Biomason in offering a chemistry-driven alternative to Portland cement with a sustainability value proposition.
- Blue Planet Systems: Produces synthetic limestone aggregates from captured CO2, replacing quarried aggregate and virgin cement. Like Biomason, focuses on permanent carbon sequestration in concrete building materials at industrial scale.
- CarbonCure: (Listed separately to flag depth of relevance) CarbonCure's direct-sale model into ready-mix concrete producers parallels Biomason's concrete-producer and licensing GTM and is the most commonly benchmarked comparable for Biomason's commercial trajectory.
Emerging players
- Brimstone: California-based startup developing carbon-negative Portland cement from calcium silicate produced without limestone (avoiding process CO2). Comparable as a next-generation cement chemistry company targeting the same decarbonization budget.
- Sublime Systems: MIT-spinout producing low-carbon cement via an electrochemical process that eliminates limestone calcination. Comparable as an emerging climate-tech cement company using a fundamentally different (non-biological) chemistry approach to the same problem Biomason addresses.
- Carbon Upcycling Technologies: Uses CO2 to produce low-carbon supplementary cementitious materials (SCMs) and concrete additives. Comparable as a Canada-based climate-tech materials company selling into the same concrete-producer customer base as Biomason.
Broad incumbents
- Heidelberg Materials: One of the world's largest building materials groups, with its evoBuild and low-carbon cement product lines directly competing for the same net-zero / LEED specifications Biomason targets — but with global scale and incumbency advantages.
- Holcim: Global cement and aggregates major marketing its ECOPlanet range of lower-carbon cements. Competes with Biomason across both structural and architectural concrete applications and has the customer relationships and capital to dominate any decarbonized cement market.
- Cemex: Global cement producer with its Vertua lower-carbon concrete portfolio. Comparable as an incumbent using blends, SCMs, and process efficiency to reduce embodied carbon — a competing pathway to Biomason's biocement.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomason social profiles
Digital presenceBiomason financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomason leadership team
Management profileNumber of profiles
Profiles15 records
Biomason subsidiaries and ownership
Company hierarchySubsidiaries1 record
Biomason funding detail
Funding detailFunding overview
Funding rounds8 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomason M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomason
What does Biomason do?
Biomason develops, manufactures, and sells biocement-based concrete products including floor tiles, pavers, blocks, and large-format precast walls. Products are made using a proprietary process in which naturally occurring microorganisms precipitate calcium carbonate crystals at ambient temperatures, binding aggregate particles into structural concrete that contains zero Portland cement and reduces CO2 emissions by up to 60% versus traditional cement. Manufacturing is conducted at the Biobeton factory in Ikast, Denmark, in partnership with IBF, with US production from the Concrete Development and Production Center in Research Triangle Park, NC.
Is Biomason a public or private company?
Biomason is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biomason founded?
Biomason was founded in 2012. It employs 51 to 100 people.
Where is Biomason based?
Biomason is headquartered in Durham, United States, in the North America region.
How does Biomason make money?
Two revenue lines are on record. Biocement Products Sales are the primary driver. The others are technology Licensing.
Who are Biomason's main competitors?
Direct peers on record are CarbonCure Technologies, Solidia Technologies, Blue Planet Systems and CarbonCure. Emerging players are Brimstone, Sublime Systems and Carbon Upcycling Technologies. Broad incumbents are Heidelberg Materials, Holcim and Cemex.
Does Biomason have an API?
No public API is recorded for Biomason.
What industry is Biomason in?
Biomason's product category is Sustainable construction materials. Its primary akta.pro industry code is IMAMALAB, Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids), with a secondary code of EUAAAIAG, Bio-based Resins, Adhesives, Coatings & Sealants. Its NAICS code is 327310 and its SIC code is 3241.